CHENGDU, Dec. 29 (NBD) -- Japanese major integrated trading and investment business conglomerate Marubeni Corporation (Marubeni) announced on Tuesday its readiness to introduce Japanese homegrown pharmaceutical products into Chinese market. 

This is the first time for Marubeni to have its merchandise on sale in overseas market. 

The Tokyo-headquartered company plans to establish a joint venture with Shanghai-based Fosun Pharmaceutical Group Co., Ltd. (Fosun) in 2017. Fosun's widespread logistics bases across China are advantageous to Marubeni's business operation in distributing Japanese pharmaceutical products to Chinese hospitals and dealers.